Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NuCana plc - American Depositary Shares (NQ:NCNA)

4.970 -0.100 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NuCana plc - American Depositary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
From NuCana plc
Via GlobeNewswire
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
From NuCana plc
Via GlobeNewswire
NCNA Stock Earnings: NuCana Beats EPS for Q2 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
NCNA Stock Earnings: NuCana Beats EPS for Q1 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
 
Via Benzinga
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
 
Via Benzinga
Topics Stocks
NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1... 
Via Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile 
From NuCana plc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data
NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival... 
Via Benzinga
NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
From NuCana plc
Via GlobeNewswire
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
From NuCana plc
Via GlobeNewswire
NuCana to Present at the Jefferies Global Healthcare Conference
From NuCana plc
Via GlobeNewswire
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
From NuCana plc
Via GlobeNewswire
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
From NuCana plc
Via GlobeNewswire
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
From NuCana plc
Via GlobeNewswire
NuCana Announces Completion of ADS Ratio Change
From NuCana plc
Via GlobeNewswire
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
From NuCana plc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... 
Via Benzinga
Why NuCana (NCNA) Shares Are Trading Lower
NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs). 
Via Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning! 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.